Search clinical trials for: Folate Receptor alpha high expression

Total 10000 results

AbbVie

Recruiting

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

Primary Peritoneal Cancer | Fallopian Tube Cancers | Advanced High-Grade Epithelial Ovarian Cancer

United States, Australia, South Korea, United Kingdom, Spain, Belgium, France, Poland
AbbVie

Active, not recruiting

A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression

Recurrent Ovarian Cancer | Folate Receptor-Alpha Positive

United States, Australia, Belgium, Canada, France, Ireland, Spain
AbbVie
Gynecologic Oncology Group; European Network of Gynaecological Oncological...

Completed

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression (MIRASOL)

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer

United States, France, Canada, Germany, China, Belgium, United Kingdom, Serbia, Taiwan, Spain, Australia, Israel, Italy, Czechia, Poland, Bulgaria, Netherlands, Portugal, Ukraine, South Korea, Russia
ImmunoGen, Inc.

Completed

A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (SORAYA)

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer

United States, Belgium, Spain, Israel, Australia, Ireland, Germany, Italy, Bulgaria, Czechia, Poland
AbbVie

Recruiting

A Study to Evaluate Folate Receptor Alpha (FRα) Expression in Adult Participants With Ovarian, Fallopian Tube, and Primary Peritoneal Cancer in Italy (FORCE)

Cancer - Ovarian

Italy

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe